Changing Lifestyles for Better Health



Status:Completed
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - 55
Updated:10/14/2017
Start Date:March 2009
End Date:July 2014

Use our guide to learn which trials are right for you!

Changing Lifestyles for Better Health: A Model Program for Community Health Centers

The purpose of this research collaboration between Dr. William Tamborlane, Deputy Directory
of the Yale Center for Clinical Investigation (YCCI) and Fair Haven Community Health Center's
(FHCHC) Diabetes Prevention Team is to determine the efficacy of an intensive life-style
intervention (ILI) program that has been developed and implemented at the FHCHC to prevent
the development of diabetes.

This project is a clinical outcome study that merges the expertise of a senior Yale clinical
investigator, the clinical and translational research resources of YCCI, the clinical and
community expertise of the FHCHC Diabetes Team, and the high-need patient population of
FHCHC. In addition to determining the efficacy and cost-effectiveness of an ILI for diabetes
prevention in an inner-city community health center setting, this project will evaluate the
effectiveness of pooling academic expertise with direct clinical services to disadvantaged,
at-risk populations.

Inclusion Criteria:

In order to be eligible for this study, the following criteria must be met:

- Subjects must be willing to travel to the clinic for all regularly scheduled study
visits, and to the lifestyle intervention program site for the ILI (the John Martinez
School).

- Subjects must have had a 2 hour 75 gram Oral Glucose Tolerance Test (OGTT) with
fasting glucose between 100 and 126, or 2 hour glucose between 140 and 200 mg/dl in
order to participate in this study within the 4 months prior to enrollment.

- Willingness to undergo fasting blood testing: HOMA-IR, fasting lipid profile
(including total cholesterol, HDL, LDL cholesterol and triglycerides) at the beginning
of the study (if not previously obtained with the OGTT) and repeated at 12 months.

- Subjects must have no medical contraindications to exercise or dieting.

Exclusion Criteria:

- Subjects will be excluded from the study if they have diabetes or other serious
medical or psychiatric condition that would preclude participation in the ILI program.

- Subjects will be excluded if they are taking medications that potentially cause
significant weight gain or weight loss (including prescription medication, over the
counter medication, or herbal supplements)..

- Women who are pregnant or planning to become pregnant will not be enrolled in this
study.

- Any behavioral or psychosocial issue that will interfere with the subject's completion
of the program, including an eating disorder will prohibit subjects from participating
in this study.

- Subjects cannot participate if they have concurrent membership in a comprehensive
weight management program.
We found this trial at
1
site
New Haven, Connecticut 06513
?
mi
from
New Haven, CT
Click here to add this to my saved trials